Pages that link to "Q55481597"
Jump to navigation
Jump to search
The following pages link to Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. (Q55481597):
Displaying 50 items.
- Energy metabolism in neurodevelopment and medulloblastoma (Q26770345) (← links)
- Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs) (Q28245465) (← links)
- Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification (Q28299667) (← links)
- Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro (Q28377506) (← links)
- Cisplatin and cranial irradiation-related hearing loss in children (Q30462703) (← links)
- Management of pediatric and adult patients with medulloblastoma (Q30847947) (← links)
- Surgical management of pediatric brain tumors (Q31139817) (← links)
- Advances in treatment of pediatric brain tumors (Q33237311) (← links)
- Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children (Q33344066) (← links)
- High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy (Q33368612) (← links)
- Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study (Q33372861) (← links)
- A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study (Q33376981) (← links)
- Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience. (Q33396889) (← links)
- Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component (Q33429765) (← links)
- Chronic oral VP-16 for recurrent medulloblastoma (Q33500996) (← links)
- The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis (Q33557891) (← links)
- Antiangiogenic therapy in the treatment of recurrent medulloblastoma in the adult: case report and review of the literature (Q33580750) (← links)
- Childhood medulloblastoma: progress and future challenges (Q33595763) (← links)
- The role of surgery in pediatric gliomas (Q33703149) (← links)
- Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy (Q33763291) (← links)
- c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients (Q33821504) (← links)
- Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in Malaysia (Q33859754) (← links)
- Common brain tumours in children: diagnosis and treatment (Q33999155) (← links)
- Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system (Q34008653) (← links)
- Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors. (Q34108929) (← links)
- Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors (Q34377726) (← links)
- What have we learnt from previous phase II trials to help in the management of childhood brain tumours? (Q34399296) (← links)
- Neural development and the ontogeny of central nervous system tumors (Q34422232) (← links)
- Novel chemotherapeutic approaches to brain tumors (Q34480131) (← links)
- Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. (Q34555820) (← links)
- Advances in biology and treatment of childhood brain tumors (Q34566385) (← links)
- Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts (Q34737158) (← links)
- Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group (Q35019735) (← links)
- What's new in neuro-oncology? Recent advances in medulloblastoma (Q35107875) (← links)
- Medulloblastoma: signalling a change in treatment (Q35721964) (← links)
- Neurosurgical treatment of brain tumors in children (Q35737424) (← links)
- Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma (Q35800791) (← links)
- Molecular analysis of pediatric brain tumors (Q35918862) (← links)
- Proton radiotherapy for solid tumors of childhood (Q35924026) (← links)
- Pediatric surgical neuro-oncology: current best care practices and strategies. (Q35939677) (← links)
- Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study (Q36025964) (← links)
- Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement (Q36048155) (← links)
- Malignant ectomesenchymoma of the cerebrum. Case report and discussion of therapeutic options (Q36061622) (← links)
- CNS Anticancer Drug Discovery and Development Conference White Paper. (Q36089590) (← links)
- Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells (Q36106864) (← links)
- Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group (Q36114760) (← links)
- Embryonic tumours of the central nervous system (Q36165420) (← links)
- Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis (Q36310718) (← links)
- High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy (Q36323766) (← links)
- Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome (Q36616158) (← links)